|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Mackay Memorial Hospital |
|---|---|
| Information provided by: | Mackay Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT00366717 |
Purpose
Cytomegalovirus (CMV) infects most of the world population. This study is to understand if chemotherapy will increase the chance of reactivating CMV. The results may help us in determining when treatment is needed and perhaps Why is it needed.
| Condition |
|---|
|
Cancer Cytomegalovirus |
| Study Type: | Observational |
| Study Design: | Screening, Longitudinal, Defined Population, Prospective Study |
| Estimated Enrollment: | 20 |
| Study Start Date: | June 2005 |
| Estimated Study Completion Date: | January 2006 |
Despite CMV reactivation has been clearly described in patients underwent transplantation, this phenomenon has not been studied in patients undergoing chemotherapy. Our purpose is to understand if CMV number increases in monocytic leukocytes during chemotherapy and how is the host response to that changes.
Virus load will be studied by quantitative PCR, host response will be studied by measuring patient's anti-CMV IgG, CMV-associated symptoms, serum IFN-r and TNF-a.
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations More Information
| Study ID Numbers: | MMH-I-S-144 |
| Study First Received: | August 18, 2006 |
| Last Updated: | August 18, 2006 |
| ClinicalTrials.gov Identifier: | NCT00366717 |
| Health Authority: | Taiwan: Department of Health |
|
Cancer under chemotherapy |
|
Virus Diseases Cytomegalovirus Infections DNA Virus Infections |
Cytomegalic inclusion disease Cytomegalovirus Herpesviridae Infections |
